{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:10:33Z","timestamp":1788588633218,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ijantimicag.2012.08.003","type":"journal-article","created":{"date-parts":[[2012,10,12]],"date-time":"2012-10-12T01:30:36Z","timestamp":1350005436000},"page":"554-556","source":"Crossref","is-referenced-by-count":54,"title":["Nitrofurantoin in the treatment of extended-spectrum \u03b2-lactamase-producing Escherichia coli-related lower urinary tract infection"],"prefix":"10.1016","volume":"40","author":[{"given":"Meltem Isikgoz","family":"Tasbakan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husnu","family":"Pullukcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguz Resat","family":"Sipahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tansu","family":"Yamazhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sercan","family":"Ulusoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2012.08.003_bib0005","first-page":"557","article-title":"A pooled analysis of the resistance patterns of Escherichia coli strains isolated from urine cultures in Turkey: a comparison of the periods 1997\u20132001 and 2002\u20132007","volume":"41","author":"Tasbakan","year":"2011","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.ijantimicag.2012.08.003_bib0010","first-page":"149","article-title":"Management of community-acquired acute bacterial cystitis in Turkey","volume":"41","author":"Coskun","year":"2011","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.ijantimicag.2012.08.003_bib0015","series-title":"Principles and practice of infectious diseases","first-page":"515","article-title":"Urinary tract agents: nitrofurantoin and methenamine","author":"Hooper","year":"2010"},{"key":"10.1016\/j.ijantimicag.2012.08.003_bib0020","first-page":"197","article-title":"In vitro efficacy of nitrofurantoin on Escherichia coli strains isolated from urine cultures","volume":"21","author":"Pullukcu","year":"2007","journal-title":"Turk J Infect"},{"key":"10.1016\/j.ijantimicag.2012.08.003_bib0025","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. Document M100-A15. Wayne, PA: CLSI; 2005."},{"key":"10.1016\/j.ijantimicag.2012.08.003_bib0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijantimicag.2006.08.039","article-title":"Fosfomycin in the treatment of extended spectrum \u03b2-lactamase-producing Escherichia coli-related lower urinary tract infections","volume":"29","author":"Pulluk\u00e7u","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.08.003_bib0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1442-2042.2010.02500.x","article-title":"Current therapy of acute uncomplicated cystitis","volume":"17","author":"Yamamoto","year":"2010","journal-title":"Int J Urol"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2012.08.003_bib0040","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1093\/clind\/15.Supplement_1.S216","article-title":"Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration","volume":"15","author":"Rubin","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.08.003_bib0045","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1590\/S0074-02762006000700006","article-title":"Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines?","volume":"101","author":"Andrade","year":"2006","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ijantimicag.2012.08.003_bib0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.diagmicrobio.2009.03.027","article-title":"Antimicrobial resistance among uropathogens that cause acute uncomplicated cystitis in women in Hong Kong: a prospective multicenter study in 2006 to 2008","volume":"66","author":"Ho","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.08.003_bib0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/jinf.2002.1091","article-title":"A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection","volume":"46","author":"Farrell","year":"2003","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2012.08.003_bib0060","first-page":"68","article-title":"Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain","volume":"20","author":"Gobernado","year":"2007","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.ijantimicag.2012.08.003_bib0065","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4065\/mcp.2010.0800","article-title":"Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis","volume":"86","author":"McKinnell","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ijantimicag.2012.08.003_bib0070","first-page":"729","article-title":"Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women","volume":"52","author":"Cristiaens","year":"2002","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.ijantimicag.2012.08.003_bib0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jac\/43.suppl_1.67","article-title":"A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection","volume":"43","author":"Iravani","year":"1999","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912003378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912003378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T06:51:40Z","timestamp":1542696700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857912003378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0924857912003378"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.08.003","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}